论文部分内容阅读
采用免疫比浊法研究急性黄疸型肝炎、慢性迁延型肝炎、慢性活动型肝炎、肝炎后肝硬化病人血中纤溶酶原的变化，并探讨其临床意义。结果表明，病人血中纤溶酶原含量按急性黄疸型肝炎、慢性迁延型肝炎、慢性活动型肝炎、肝炎后肝硬化的顺序依次减少，且慢性活动型肝炎及肝炎后肝硬化病人血中的纤溶酶原含量明显低于正常人及前两种肝炎病人。经统计学处理，Ｐ＜０．０１，说明纤溶酶原可作为反映肝脏功能损伤程度及病情的指标。
Immunocytometry was used to study the changes of blood plasminogen in patients with acute jaundice hepatitis, chronic persistent hepatitis, chronic active hepatitis and posthepatitic cirrhosis, and to explore the clinical significance. The results showed that the content of plasminogen in patients with acute jaundice hepatitis, chronic persistent hepatitis, chronic active hepatitis, hepatitis cirrhosis in the order of decreasing, and chronic active hepatitis and hepatitis in patients with cirrhosis of the liver Plasminogen content was significantly lower than normal and the first two patients with hepatitis. Statistically, P <0.01, indicating that plasminogen can be used as a reflection of the degree of liver damage and disease indicators.